El-Hibri Fuad Blog

Posts Tagged ‘Healthcare Conference

ROCKVILLE, Md.–(BUSINESS WIRE)–Feb. 20, 2012– Emergent BioSolutions Inc. (NYSE: EBS) announced today that the company will be webcasting its corporate overview presentation at the 32nd Annual Cowen and Company Health Care Conference in Boston on Monday, March 5, 2012 at 3:40 PM Eastern.

A webcast of this presentation will be available both live and by replay, accessible from the Emergent website http://www.emergentbiosolutions.com under “Investors”.

About Emergent BioSolutions Inc.

Emergent BioSolutions, led by Chairman and CEO Fuad El-Hibri, protects and enhances life by developing and manufacturing vaccines and therapeutics that are supplied to healthcare providers and purchasers for use in preventing and treating disease. Emergent’s marketed and investigational products target infectious diseases, oncology and autoimmune disorders. Additional information about the company may be found at http://www.emergentbiosolutions.com.

Source: Emergent BioSolutions Inc.

Emergent BioSolutions Inc.

Investors:

Robert G. Burrows, 301-795-1877

Vice President, Investor Relations

BurrowsR@ebsi.com

or

Media:

Tracey Schmitt, 301-795-1800

Vice President, Corporate Communications

SchmittT@ebsi.com

Published Date : February 20, 2012

Fuad El-Hibri, CEO of Emergent BioSolutions Inc., announces that the company will be participating in the following investor conferences during June 2010:

  • The Jefferies & Company 2010 Global Life Sciences Conference
    New York, NY.
    June 8, 2010
    Corporate Overview Presentation
    11:00 AM Eastern
    There will be a full webcast with slides that will include discussion of the Company’s business activities, financial outlook and current news.
  • The Needham & Company 9th Annual Healthcare Conference
    New York, NY.
    June 10, 2010
    Corporate Overview Presentation
    3:20 PM Eastern
    There will be a full webcast with slides that will include discussion of the Company’s business activities, financial outlook and current news.

Both webcasts will be accessible from the Emergent website www.emergentbiosolutions.com under “Investors”.